Drug Search Results
More Filters [+]

Encenicline

Alternative Names: encenicline, evp-6124, mt-4666
Latest Update: 2024-05-06
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: nAChR Agonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: FORUM
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Encenicline

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Schizophrenia|Cognitive Dysfunction|Alzheimer Disease

Phase 2: Tobacco Use Disorder|Smoking Cessation|Alzheimer Disease|Schizophrenia

Phase 1: Affective Disorders, Psychotic|Alzheimer Disease|Psychotic Disorders|Schizophrenia|Kidney Diseases|Other|Healthy Volunteers

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

EVP-6124-026

P3

Terminated

Alzheimer Disease

2017-08-01

EVP-6124-024

P3

Terminated

Alzheimer Disease

2017-01-01

EVP-6124-025

P3

Terminated

Alzheimer Disease

2017-01-01

EVP-6124-027

P2

Withdrawn

Alzheimer Disease

2016-10-01

Recent News Events